Signet Jewelers Ltd (SIG) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. Despite short-term price weakness, the company's strong financial performance, positive hedge fund activity, and AI-driven operational improvements suggest significant growth potential. Analysts have also highlighted tailwinds from lab-grown diamonds and AI-driven e-commerce enhancements, which align with long-term value creation.
The stock is currently trading at $90.11, down 3.87% in the regular market. The MACD is negative and expanding (-0.656), indicating bearish momentum. RSI is at 26.901, suggesting the stock is oversold. Key support is at $90.387, with resistance at $94.963. The stock has a 40% chance of a slight decline (-2.08%) in the next day but a 6.54% chance of growth in the next week.

Hedge funds are significantly increasing their positions in SIG, with a 205.96% increase in buying activity last quarter.
The company is leveraging AI to enhance e-commerce and inventory management, which is expected to drive significant growth.
Analysts have highlighted the shift in lab-grown diamonds from a headwind to a tailwind, boosting growth and earnings.
Financials show strong YoY growth in revenue (+3.14%), net income (+270.37%), and EPS (+308.33%).
The stock is currently experiencing bearish momentum, with MACD and RSI indicating short-term weakness.
The broader market (S&P
is down by 1.16%, which may weigh on investor sentiment.
In Q3 2026, Signet Jewelers reported revenue of $1.3918 billion (+3.14% YoY), net income of $20 million (+270.37% YoY), and EPS of $0.49 (+308.33% YoY). Gross margin improved to 37.28%, up 3.67% YoY, reflecting strong operational efficiency.
Recent analyst ratings are mixed but lean positive. Jefferies raised its price target to $150 (from $130) with a Buy rating, citing growth tailwinds from lab-grown diamonds. Goldman Sachs initiated coverage with a Neutral rating and a $96 price target, emphasizing opportunities in pricing power and store growth. Morgan Stanley raised its price target to CHF 12.70 but maintained an Equal Weight rating.